Bahrain vs Guatemala: The number of people with susceptibility test result for rifampicin
Bahrain
94.12
in 2021
Guatemala
95.02
in 2021
Bahrain rank
54th
Guatemala rank
51st
The number of people with susceptibility test result for rifampicin over time
- Bahrain
- Guatemala
How they compare
Guatemala currently reports 95.02 against 94.12 in Bahrain, a difference of 0.9.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Bahrain ahead.
Bahrain ranks 54th and Guatemala ranks 51st of 146 countries.
Bahrain has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bahrain | Guatemala | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 97.36 | 43.35 | 54.01 | Bahrain |
| 2020s | 86.48 | 64.93 | 21.56 | Bahrain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bahrain or Guatemala?
- Guatemala, at 95.02 against 94.12 in Bahrain as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bahrain and Guatemala?
- 0.9, with Guatemala ahead.
- How many years of comparable data are there for Bahrain and Guatemala?
- 5 years are reported by both, from 2017 to 2021.
- How do Bahrain and Guatemala rank globally for the number of people with susceptibility test result for rifampicin?
- Bahrain ranks 54th and Guatemala ranks 51st of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.